OraSure Technologies Inc. (OSUR)
-NasdaqGS | Prev Close: | 4.01 |
|---|
| Open: | N/A |
|---|
| Bid: | 3.35 x 400 |
|---|
| Ask: | 4.44 x 1000 |
|---|
| 1y Target Est: | 9.44 |
|---|
| Beta: | 1.38 |
|---|
| Next Earnings Date: | 7-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 4.01 - 14.01 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 403,680 |
|---|
| Market Cap: | 222.67M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.41 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 3 Key Advances in HIV Preventionat Motley Fool(Sat, Jun 15)
- 1 Reason OraSure Technologies May Be Headed for a Slowdownat Motley Fool(Wed, Jun 12)
- 5 Stocks Under $10 Set to Soarat TheStreet(Thu, Jun 6)
- OraSure Technologies to Present at Jefferies 2013 Global Healthcare ConferenceGlobeNewswire(Tue, May 28)
- Stalled Progress in the Fight Against HIV?at Motley Fool(Sat, May 25)
- OraSure Technologies Getting Very Oversold (OSUR)at TheStreet(Thu, May 23)
- OSUR January 2014 Options Begin Tradingat TheStreet(Mon, May 20)
- ORASURE TECHNOLOGIES INC FinancialsEDGAR Online Financials(Fri, May 17)
- A Contrarian Approach to Investing in Health Care: Expert Portfolio Manager Mark W. Oelschlager Interviews with The Wall Street TranscriptWall Street Transcript(Fri, May 17)
- ORASURE TECHNOLOGIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Fri, May 17)
- OraSure Technologies' CEO Presents at Annual Shareholder Meeting Conference (Transcript)at Seeking Alpha(Wed, May 15)
- OraSure Technologies, Walgreens and Chronic Liver Disease Foundation to Launch Rapid Hepatitis C Testing Initiative in Support of National Hepatitis Testing DayGlobeNewswire(Mon, May 13)
- Investors Ride 5 Healthcare Earnings Rollercoaster Ridesat Wall St. Cheat Sheet(Sun, May 12)
- Tech That Disrupts Our Lives for the BetterTheStreet(Fri, May 10)
- OraSure Technologies to Webcast Annual Meeting of StockholdersGlobeNewswire(Fri, May 10)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| OSUR | 0.00% | 222.67M |
| BAX | 0.00% | 37.75B |
| COV | 0.00% | 29.91B |
| CSRT.L | 0.27% | 228.80M |
| BDX | 0.00% | 19.19B |
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.53 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.55 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.16 |
|---|
| Mean Recommendation*: | 1.6 |
|---|
| PEG Ratio (5 yr expected): | -0.38 |
|---|
Business Summary
OraSure Technologies, Inc. develops, manufactures, and markets oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.
View More